JNCCN 360 - Bladder - Ongoing CE Activities

Editor:

Thomas Flaig, MD

Advertisement

Advertisement

Ongoing CE Activities

Archived Monthly Oncology Tumor Boards: Treatment of Patients with Bladder and Upper Tract Urothelial Cancer

Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Bladder Cancer

Breakfast with the Investigators: Urothelial Bladder Cancer

Cases from the Community: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Urothelial Bladder Cancer

Data-driven Debates on the Evolving Bladder Cancer Landscape: Harnessing Novelty to Improve Outcomes

Metastatic Urothelial Carcinoma: 2020 Multidisciplinary Molecular Tumor Board

Novel Therapies for Non-Muscle Invasive Bladder Cancer: Exploring the Role of Immune Checkpoint Inhibitors

Oncology Today with Dr Neil Love: Management of Nonmetastatic Urothelial Bladder Cancer

What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation in Urothelial Bladder Cancer

Sections

NCCN Resources

Copyright © 2022 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.